Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NCOA1 | Q15788 | 1/20 | 0.33 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 3/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19764706 | 0.84 | PTPRC (0.35) | MEN1KMT2AKDM4ELMNAMAPT | |
| SCHEMBL19764691 | 0.84 | ALDH1A1 (0.34) | MEN1KMT2AKDM4ELMNAMAPT | |
| SCHEMBL19764689 | 0.84 | NCOA1 (0.33) | NCOA1NCOA3ATMMEN1KMT2A | |
| SCHEMBL19764705 | 0.74 | BACE1 (0.43) | ATMMEN1KMT2ALMNAMAPT | |
| SCHEMBL19764708 | 0.72 | MEN1 (0.41) | ATMMEN1KMT2AKDM4ELMNA | |
| SCHEMBL14380302 | 0.70 | CYP3A4 (0.43) | NCOA1NCOA3ATMMEN1KMT2A | |
| SCHEMBL28267231 | 0.70 | NOX1 (0.41) | MEN1KMT2AKDM4ELMNAMAPT | |
| SCHEMBL19764656 | 0.70 | CYP3A4 (0.43) | NCOA1NCOA3ATMMEN1KMT2A | |
| SCHEMBL27363836 | 0.70 | CYP3A4 (0.43) | NCOA1NCOA3ATMMEN1KMT2A | |
| SCHEMBL19764683 | 0.70 | ESR1 (0.40) | MEN1KMT2AKDM4ELMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10566547-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-02-18 | — | — | US | disclosed |
| US-20180013074-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2018-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10566547-B2 | Organic electroluminescent materials and devices | PAX2, EYA2, NLRP1 | NCOA1 860/4885NCOA3 1450/4885ATM 2944/4885 |
| US-20180013074-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | PAX2, EYA2, NLRP1 | NCOA1 860/4885NCOA3 1450/4885ATM 2944/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.